IFC plans to invest $75 million in Glenmark Pharma

17 Jun 2016 Evaluate

International Finance Corporation (IFC) is planning to invest up to $75 million (around Rs 500 crore) in Glenmark Pharmaceuticals. The pharma major is aiming to raise up to $200 million through market issuance of quasi-equity instruments in order to reduce debt and expand operations, of which IFC proposes to invest up to $75 million.

The proposed investment will allow Glenmark to expand its manufacturing capacity mainly in India, to build research and development capacity for new molecules and to reduce some debt so that internal accruals can be deployed more for R&D.

Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. It manufactures and markets generic formulation products and active pharmaceutical ingredients, both in the domestic and international markets.

Glenmark Pharma Share Price

2029.70 0.10 (0.00%)
31-Dec-2025 14:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.65
Dr. Reddys Lab 1270.50
Cipla 1508.10
Zydus Lifesciences 913.35
Lupin 2111.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×